If you look at the timeline of human survival, the invention of insulin therapy stands out as a miracle of the 20th century. Before this discovery, a diagnosis of type 1 diabetes was effectively a death sentence. The body simply stopped producing the hormone needed to process glucose. Doctors were helpless.
In the 1800s, researchers knew insulin was essential for burning energy. They tried everything to replace it. Some physicians fed fresh pancreas tissue to patients. It failed. It likely caused severe digestive distress along with the lack of medical benefit. Other attempts to extract and replace the missing hormone also flopped.
Then came 1922. Dr. Frederick Banting, a former divinity student, figured out how to isolate insulin from a dog’s pancreas. His colleagues were unimpressed. They described the extract as “thick brown muck.” But Banting injected it into Leonard Thompson, a 14-year-old boy weighing just 65 pounds because his body had consumed itself.
The first attempt was messy. Leonard developed abscesses from the injection. He still felt terrible. His blood sugar only dropped slightly. But it was a start. Banting refined the formula. Six weeks later, he injected a cleaner version into Leonard.
The change was rapid. Blood sugar fell from a dangerous 520 mg/dl to a manageable 120 mg/dl. Weight returned. Strength returned. Leonard lived with controlled diabetes for years. He eventually died of pneumonia at age 27, but he had been given time he never would have had otherwise.
Banting and his colleague Dr. John Macleod received the Nobel Prize for this breakthrough. Commercial production followed quickly. For decades, the insulin supply came from slaughterhouses. Manufacturers extracted hormones from the pancreases of cows and pigs. These animals provided the bulk of the insulin used to treat millions of people.
Animal insulin saved countless lives. It also caused allergic reactions in some users. The human body sometimes rejected the animal protein. That changed in 1978.
Genentech, a new biotechnology firm, produced the first synthetic human insulin. They used bacteria and yeast as tiny factories. Human insulin genes were inserted into the DNA of these microorganisms. The result was recombinant DNA insulin. It matched human physiology perfectly. It eliminated the allergic issues associated with animal derivatives.
By the early 1980s, this new form was widely available. It changed diabetes treatment permanently. Today, almost everyone requiring insulin uses recombinant human insulin. Animal insulin is largely a thing of the past.
Understanding Your Insulin Options
For those managing type 1 diabetes or advanced type 2, understanding the source of insulin matters. The shift from animal to synthetic sources removed a significant barrier to care. Allergies decreased. Consistency improved.
Current data on medication usage shows a varied landscape. About 16% of people with diabetes take insulin only. 12% use both insulin and oral medications. A majority, 57%, rely on oral medications alone. Another 15% do not use either insulin or oral drugs, often managing through lifestyle changes alone.
The distinction between proven clinical history and early research is clear here. The benefits of recombinant insulin are established facts. The mechanisms of bacterial production are well-documented. This is not experimental. It is the standard of care.
If you are curious about the specifics, resources are available. General diabetes pages cover diagnosis and symptoms. Specialized pages detail treatments for type 1 diabetes. The evolution from pig pancreas to bacterial synthesis is one of medicine’s greatest success stories. It turned a fatal condition into a manageable one.
The science continues to advance. New delivery methods are being tested. New analogs are being designed. But the core principle remains the same. Insulin is not optional. It is essential. And thanks to Banting, Thompson, and the biotech pioneers who followed, it is accessible.
You don’t need to be a scientist to appreciate that. You just need to be alive.















